InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Nanavaty Maulik, Vice-Président Senior. Director active across 2 companies, notably Boston Scientific CORP. In total, 10 disclosures have been recorded. Split: 1 buy · 1 sell. Total volume traded: €2.7m. Activity tracked since 28 May 2021. The latest transaction was filed on 16 November 2023 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Nanavaty Maulik
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
500 shares@ US$1.98100.0% of flowClass A Common StockSEC:0000950170-23-064982:0
Canonical exit: 14 Feb 2024 (T+90)
1,630 shares0Common StockSEC:0001225208-22-003865:0
1,714 shares0Common StockSEC:0001225208-22-003085:0
2,166 shares0Common StockSEC:0001225208-22-002924:0
1,661 shares0Common StockSEC:0001225208-22-002681:0
11,017 shares0Class A Common StockSEC:0001209191-22-007638:0
6,175 shares0Common StockSEC:0001225208-22-000115:0
78,192 shares@ US$42.5931100.0% of flowCommon StockSEC:0001225208-21-008788:0
17,150 sharesCommon StockSEC:0001225208-16-023464:0
6,797 sharesCommon StockSEC:0001225208-16-023464:1
10 of 10 declarations
About Nanavaty Maulik
Maulik Nanavaty is Senior Vice President and President, Neuromodulation at BOSTON SCIENTIFIC CORP and Board Member at Rani Therapeutics Holdings, Inc. He is responsible for leading neuromodulation initiatives within the company.
